drugset / Trial / NCT02571608
Continuation of Metformin to Improve And Keep Peri-operative Glycemic Control
RandomizedParallel-groupQuadruple-blindTreatment
Summary
Type II Diabetes Mellitus patients having surgery who adhere to their regular scheduled metformin dosing and take this medication on the morning of surgery will have better glycemic control peri-operatively and potentially suffer less morbidity compared to individuals taking a placebo.
Timeline
- Start
- 2022-01-01
- Primary completion
- 2022-12-31
- Completion
- 2022-12-31
Outcome
Outcome not reported
Stopped (Enrollment): “Study halted prematurely, prior to enrollment of first participant”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Metformin | Small molecule | — | — |